Lixisenatide,10 microgram/0.2 mL injection, 14 unit doses (&) 20 microgram/0.2 mL injection, 14 unit doses, Lyxumia® treatment initiation pack;

Lixisenatide, 20 microgram/0.2 mL injection, 2 x 14 unit doses, (for dual and triple therapy) Lyxumia®, Sanofi-Aventis Australia Pty Ltd

• Public Summary Document (PSD) July 2014 PBAC Meeting - (PDF 140 KB)
• Public Summary Document (PSD) July 2014 PBAC Meeting - (Word 82 KB)